Brett S Lowe

机构：University of London, London School of Hygiene & Tropical Medicine · ORCID：0000-0002-4422-8627

发表论文 155 篇 · 总被引 10826 次 · h-index 55

代表论文

• Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial (2022 · The Lancet Global Health · 被引 119)
• Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial (2021 · The Lancet Infectious Diseases · 被引 100)
• Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial (2021 · The Lancet Infectious Diseases · 被引 96)
• Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya (2019 · BMC Medicine · 被引 63)
• Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria (2023 · Science Translational Medicine · 被引 34)
• Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial (2022 · The Lancet Infectious Diseases · 被引 27)